Sword Health, the world’s leading digital musculoskeletal (MSK) therapy provider, has acquired Kaia Health in a $285 million deal that unites two of the most prominent AI-driven platforms in the space. The acquisition, finalised on January 24, 2026, creates a combined entity with unmatched scale, clinical depth, and technological breadth in digital MSK care serving employers, health plans, and health systems across the United States, Germany, and beyond.

Kaia Health, founded in Munich and with a strong European footprint, has built a highly regarded self-guided digital therapy platform that uses AI to deliver personalised exercise programmes, education, and behavioural support for conditions including chronic back pain, osteoarthritis, COPD, and hypertension. Its app-based model has been clinically validated in multiple randomised controlled trials and boasts high user engagement and retention rates, particularly in Germany where it is widely reimbursed by statutory health insurers.

Sword Health, headquartered in Portugal with major operations in the U.S., has differentiated itself through a hybrid model that pairs AI-driven exercise guidance with dedicated physical therapists for personalised oversight. The company has grown rapidly in the employer sponsored and health plan markets, serving millions of members with demonstrable reductions in pain, surgery rates, and opioid use.

The combination brings complementary strengths: Sword’s therapist guided care and enterprise grade integrations with Kaia’s fully automated, scalable self-service model. Together, they will offer a full spectrum of MSK care from fully digital pathways for low acuity cases to high touch, therapist supported programmes for complex or post-surgical patients. The merged platform will leverage Kaia’s multimodal data (motion tracking, symptom reporting, adherence patterns) and Sword’s clinical outcome datasets to further refine AI models for personalised care pathways, predictive risk scoring, and early intervention.

Sword Health CEO Virgílio Bento commented: “Kaia and Sword have both proven that digital MSK care works clinically, economically, and for patients. By bringing these two leading approaches together, we can offer the right level of care at the right time for every individual, while accelerating innovation and expanding access globally.”

The deal includes the full integration of Kaia’s technology stack and team into Sword Health. Kaia’s Munich office will serve as a key European hub, supporting continued growth in Germany and expansion across the EU. Existing Kaia users will experience no disruption in service, with seamless transition to Sword’s enhanced platform planned over the coming months.

The acquisition reflects the ongoing consolidation in digital therapeutics and the increasing strategic importance of AI-driven MSK solutions in value-based care models. With combined annual revenue exceeding $200 million and a rapidly growing membership base, the merged entity is well positioned to capture a larger share of the global digital MSK market, projected to reach $10–15 billion by 2030.